4Bello BD,Spinillo A,Alberizzi P,et al.Cervical infections by multiple human papillomavirus (HPV) genotypes:prevalence and impact on the risk of precancerous epithelial lesions.J Med Virol,2009,81:703-712.
5Insinga RP,Glass AG,Rush BB.Diagnoses and outcomes in cervical cancer screening:a population-based study.Am J Obstet Gynecol,2004,191:105-113.
6Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000,Int J Cancer,2001,94:153-156.
7Khan K,Curtis CR,Ekwueme DU,et al.Preventing cervical cancer:overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.Cancer,2008,113:3004-3012.
8Dai M,Bao YP,Li N,et al.Human papillomavirus infection in Shanxi Province,People's Republic of China:a population-based study.Br J Cancer,2006,95:96-101.
9Sodhani P,Gupta S,Singh V,et al.Sensitivity of the Pap test in detecting high grade lesions:what should be the acceptable cytologic threshold for colposcopic referral? Acta Cytol,2006,50:181-184.
10WHO.Comprehensive cervical cancer control:a guide to essential practice.Switzerland:WHO,2006:79-124.
